Endothelial differentiation potential of neonatal rat cardiac fibroblasts

ZHANG Jun-yue YIN Guo-tian GUO Zhi-kun

Acta Anatomica Sinica ›› 2018, Vol. 49 ›› Issue (4) : 443-449.

PDF(1183 KB)
Welcome to visit Acta Anatomica Sinica! Today is Chinese
PDF(1183 KB)
Acta Anatomica Sinica ›› 2018, Vol. 49 ›› Issue (4) : 443-449. DOI: 10.16098/j.issn.0529-1356.2018.04.005
Cell and Molecules Biology

Endothelial differentiation potential of neonatal rat cardiac fibroblasts

  • ZHANG Jun-yue1 YIN Guo-tian2 GUO Zhi-kun 1*
Author information +
History +

Abstract

Objective  To investigate the differentiation of cardiac fibroblasts (CFSs) into endothelial cells and the potential for vascularization, and to provide a cytological and theoretical basis for clinical treatment of myocardial injury. Methods  CFSs were isolated, cultured and purified from the fresh left ventricular tissue. The 3rd generation of CFSs was induced by endothelial cells induced medium for 28 days. After continuous induction culture of 28 days, the endothelial cell medium (ECM) was replaced, digested and passaged down to P3 generation. The growth and morphological changes of the induced cells were detected. The expression of the endothelial cell markers and functional characteristics in the induced cells were evaluated by immunocytochemistry, flow cytometry and angiogenesis analysis. Results  The third generation of CFSs in neonatal rats was triangular, spindle and polygonal, and the rate of proliferation was rapid. Vimentin and discoidin domain receptor 2(DDR2) expressions were positive. The 3rd generation of CFSs was cultured for 3 hours and the induced medium was added, cells began to converge after 3 days, the cells formed string beads were induced at 21 days, and the cells were pooled into the ring shape at 28 days. The immunohistochemistry staining showed that vWF and CD31 were positively expressed in the differentiated cells, but not expressed in the control group. The immunofluorescence staining shows that vWF, CD34 and CD105 were positive in the experimental group, but not in the control group. Flow cytometry analysis showed that the expression rate of CD31 was 50.5% in the induced cells, whereas the expression in the control group was just 5.82%. Conclusion  Cardiac fibroblasts induced with vascular endothelial growth factor(VEGF) and basic fibroblast growth factor(bFGF ) can differentiate into vascular endothelial cells in vitro, and have the characteristics and functions of vascular endothelial cells.

Key words

Vascular endothelial growth factor / Basic fibroblast growth factor(bFGF) / Cardiac fibroblast / Endothelial Cell differentiation / Cell culture / Rat

Cite this article

Download Citations
ZHANG Jun-yue YIN Guo-tian GUO Zhi-kun. Endothelial differentiation potential of neonatal rat cardiac fibroblasts[J]. Acta Anatomica Sinica. 2018, 49(4): 443-449 https://doi.org/10.16098/j.issn.0529-1356.2018.04.005

References

[1] Chang Y,Li H,Guo Z. Mesenchymal stem cell- like properties in fibroblasts[J].Cell Physiol Biochem,2014,34(3):703-714.
[2] Li J, Huang NF,Zou J, et al. Conversion of human fibroblasts to functional endothelial cells by defined factors[J]. Arterioscler Thromb Vasc Biol,2013,33(6):1366-1375.
[3] Ubil E, Duan J, Pillai IC, et al. Mesenchymal-endothelial transition contributes to cardiac neovascularization[J].Nature, 2014, 514(7524):585-590.
[4] Munoz-Chapuli AR, Quesada R, Angel M.Angiogenesis and signal transduction in endothelial cells[J]. Cell Mol Life Sci,2004,61 (17): 2224-2243.
[5] Lamalice, LF, Le B, Huot J. Endothelial cell migration during angiogenesis[J]. Circ Res, 2007,100(6):782-794.
[6] Prasad CK, Krishnan LK. Effect of passage number and matrix characteristics on differentiation of endothelial cells cultured for tissue engineering[J]. Biomaterials,2005, 26(28):5658-5667.
[7] Takahashi T, Kalka C, Masuda H, et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization[J]. Nat Med, 1999,5(4):434-438.
[8] Heeschen C, Lehmann R, Honold J, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease[J]. Circulation, 2004, 109(13):1615-1622.
[9] Miyahara Y, Nagaya N, Kataoka M, et al. Monolayered mesenchymal stem cells repair scarred myocardium after myocardial infarction[J]. Nat Med, 2006,12(4):459-465.
[10] Strauer BE, Steinhoff G. 10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice[J]. J Am Coll Cardiol, 2011,58(11):1095-1104.
[11] Dimmeler S, Burchfield J, Zeiher AM. Cell-Based therapy of myocardial infarction[J]. Arterioscler Thromb Vasc Biol, 2008, 28(2):208-216.
[12] Ayvazyan A, Morimoto N, Kanda N, et al. Collagen-gelatin scaffold impregnated with bFGF accelerates palatal wound healing of palatal mucosa in dogs[J]. J Surg Res, 2011, 171(2):247-257.
[13] Florkiewicz RZ, Ahluwalia A, Sandor Z, et al. Gastric mucosal injury activates bFGF gene expression and triggers preferential translation of high molecular weight bFGF isoforms through CUG-initiated, non-canonical codons[J]. Biochem Biophys Res Commun, 2011, 409(3):494-499.
[14] Sun D, Liu Y, Yu Q, et al. The effects of luminescent ruthenium(Ⅱ) polypyridyl functionalized selenium nanoparticles on bFGF-induced angiogenesis and AKT/ERK signaling[J]. Biomaterials, 2013, 34(1):171-180.
[15] Nikolova-Krstevski Ⅴ, Bhasin M, Otu HH, et al. Gene expression analysis of embryonic stem cells expression VE-cadherin(CD144) during endothelial differentiation[J]. BMC Genomics, 2008, 9:240.
[16] Barrientos S, Stojadinovic O, Golinko MS, et al. Growth factors and cytokines in wound healing[J]. Wound Repair Regen, 2008, 16(5):585-601.
[17] Oswald J, Boxberger S, Jorgensen B, et al. Mesenchymal stem cells can be differentiated into endothelial cells in vitrol[J]. Stem Cells, 2004, 22(3): 377-384.
[18] Cho SW, Park HJ, Ryu JH, et al. Vascular patches tissu.e engineered with autologous bone marrow derived cells and decellularized tissue matrices[J]. Biomaterials, 2005, 26(14):1915-1924.
[19] Zhang M, Wang Z, Wang Z, et al. Immobilization of anti-CD31 antibody on electrospun poly (-caprolactone) scaffolds through hydrophobins forspecific adhesion of endothelial cells[J]. Colloids Surf Biointerfaces, 2011,85(1):32-39.
[20] Laouari D, Yang R, Veau C, et al. Two apical multidrug transporters, P-gp and MRP2, are differently altered in chronic renal failure[J]. Am J Physiol Renal Physiol, 2001, 280(4):636-645
[21] Tanaka F,Otake Y,Yanagihara K,et al.Evaluation of angiogenesis in non-small cell lung cancer:comparison between anti-CD34 antibody and anti-CD105 antibody [J].Clin Cancer Res,2001,7(11):3410-3415.
PDF(1183 KB)

Accesses

Citation

Detail

Sections
Recommended

/